Skip to content

A Prospective, Randomised, Double-blind, Placebo Controlled Study to assess the Role of Aloe Vera with or without Glucosamine & Chondroitin in Patients with Symptomatic Osteoarthritis of Knees

A Prospective, Randomised, Double-blind, Placebo Controlled Study to assess the Role of Aloe Vera with or without Glucosamine & Chondroitin in Patients with Symptomatic Osteoarthritis of Knees

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN01562001
Enrollment
Unknown
Registered
2007-09-28
Start date
2006-04-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases: Osteoarthritis of the knee Musculoskeletal Diseases Osteoarthritis of the knee

Interventions

Aloe vera with or without glucosamine and Chondroitin

Sponsors

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 - 80 years 2. Symptoms of episodic or continuous pain in the affected knee joint for 6 weeks 3. Diagnosis of OA of Knee made according to ACR criteria (knee pain and radiographic osteophytes and at least any one of the following 3 items: a) Age > 50 years b) Morning Stiffness < 30 minutes in duration c) Crepitus on motion

Exclusion criteria

Exclusion criteria: 1. Any contra indication to Aloe Vera /Glucosamine/Chondroitin 2. Current Use or use within 3 months of screening of aloe vera/Glucosamine/Chondroitin 3. Current or Previous history of oral steroid or injection in the study joint within 3 months 4.Current or previous history of Intra articular Synvisc or Hyalgan therapy 5. Previous history of NSAID topical application within the last 3 months 6. Any previous history of Knee surgery including Menisectomy / patellectomy etc 7. Presence of Inflammatory Arthritis 8. Presence of significant hip disease on the side of symptomatic knee

Design outcomes

Primary

MeasureTime frame
1. Assessment and comparison of overall symptoms including pain, range of motions and variables such as swelling etc in the affected joints and other measures of functional aspects of the joint 2. Assessment of Quality of life

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026